Drug Enforcement Administration April 2019 – Federal Register Recent Federal Regulation Documents

Interlocutory Appeals in Administrative Hearings
Document Number: 2019-08705
Type: Rule
Date: 2019-04-30
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration is amending its hearing regulations to provide that, when the presiding officer of an administrative hearing denies an interlocutory appeal, he shall transmit his determination to the Drug Enforcement Administration Administrator for discretionary review.
Palafox Pharmacy; Decision and Order
Document Number: 2019-08703
Type: Notice
Date: 2019-04-30
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Mylan Pharmaceuticals Inc.
Document Number: 2019-08702
Type: Notice
Date: 2019-04-30
Agency: Drug Enforcement Administration, Department of Justice
Chemical Names of Previously Controlled Fentanyl-Related Substances
Document Number: 2019-07457
Type: Rule
Date: 2019-04-19
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing additional descriptive information with respect to five specific substances already covered by a temporary scheduling order that appeared in the Federal Register on February 6, 2018. That order placed fentanyl-related substances temporarily in schedule I of the Controlled Substances Act. The order further stated that if and when DEA identifies a specific new substance that falls under the definition of a fentanyl-related substance, the agency will publish in the Federal Register, and on the agency website, the chemical name of such substance. Consistent therewith, this document provides the chemical names of five substances that fall within the definition of fentanyl- related substances that were temporarily controlled under the scheduling order issued February 6, 2018.
Schedules of Controlled Substances: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 into Schedule I
Document Number: 2019-07460
Type: Rule
Date: 2019-04-16
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic cannabinoids (SC), ethyl 2-(1-(5-fluoropentyl)-1H- indazole-3-carboxamido)-3,3-dimethylbutanoate (trivial name: 5F-EDMB- PINACA); methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3- dimethylbutanoate (trivial name: 5F-MDMB-PICA); N-(adamantan-1-yl)-1- (4-fluorobenzyl)-1H-indazole-3-carboxamide (trivial names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL)); 1-(5-fluoropentyl)-N-(2- phenylpropan-2-yl)-1H-indazole-3-carboxamide (trivial names: 5F-CUMYL- PINACA; SGT-25); and (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl) methanone (trivial name: FUB-144), and their optical, positional, and geometric isomers, salts, and salts of isomers in schedule I. This action is based on a finding by the Acting Administrator that the placement of these SCs in schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB- AKB48, 5F-CUMYL-PINACA or FUB-144.
Importer of Controlled Substances Application: Sanyal Biotechnology, LLC
Document Number: 2019-06854
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I
Document Number: 2019-06853
Type: Proposed Rule
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration proposes placing methyl 2- (1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbu tanoate [5F-ADB; 5F-MDMB-PINACA]; methyl 2-(1-(5-fluoropentyl)-1H-indazole-3- carboxamido)-3-methylbutanoate [5F-AMB]; N-(adamantan-1-yl)-1-(5- fluoropentyl)-1H-indazole-3-carboxamide [5F-APINACA, 5F-AKB48]; N-(1- amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-ind azole-3- carboxamide [ADB-FUBINACA]; methyl 2-(1-(cyclohexylmethyl)-1H-indole-3- carboxamido)-3,3-dimethylbutanoate [MDMB-CHMICA, MMB-CHMINACA] and methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3- dimethylbutanoate [MDMB-FUBINACA], including their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA.
Importer of Controlled Substances Application: SpecGx LLC
Document Number: 2019-06852
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Extension of Temporary Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I of the Controlled Substances Act
Document Number: 2019-06851
Type: Rule
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to extend the temporary schedule I status of six synthetic cannabinoids (SC). The substances are: methyl 2-(1-(5-fluoropentyl)-1H-indazole-3- carboxamido)-3,3-dimethylbutanoate [5F-ADB; 5F-MDMB-PINACA]; methyl 2- (1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutano ate [5F- AMB]; N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxami de [5F-APINACA, 5F-AKB48]; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole-3-carboxamide [ADB-FUBINACA]; methyl 2-(1- (cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutan oate [MDMB-CHMICA, MMB-CHMINACA] and methyl 2-(1-(4-fluorobenzyl)-1H- indazole-3-carboxamido)-3,3-dimethylbutanoate [MDMB-FUBINACA], including their optical, positional and geometric isomers, salts, and salts of isomers. The schedule I status of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA will expire on April 10, 2019. This temporary order will extend the temporary scheduling of 5F- ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA for one year or until the permanent scheduling action for these six substances is completed, whichever occurs first.
Importer of Controlled Substances Application: Unither Manufacturing LLC
Document Number: 2019-06850
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Organic Standards Solutions International, LLC
Document Number: 2019-06849
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-06848
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has submitted an application for registration to the Drug Enforcement Administration (DEA) to become a bulk manufacturer of various classes of schedule I controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-06847
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The applicant listed below has submitted an application for registration to the Drug Enforcement Administration (DEA) to become an importer of schedule I controlled substances.
Bulk Manufacturer of Controlled Substances Application: Synthcon, LLC
Document Number: 2019-06846
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Registration
Document Number: 2019-06845
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The applicant listed below has submitted an application for registration to the Drug Enforcement Administration (DEA) to become an importer of a schedule I controlled substance.
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-06844
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of schedule II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-06843
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and been granted a registration by the Drug Enforcement Administration (DEA) as an importer of schedule II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-06842
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I or schedule II controlled substances.
Martin A. Barrios, M.D.; Decision and Order
Document Number: 2019-06836
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
Richard Carter, M.D.; Decision and Order
Document Number: 2019-06835
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice
Craig M. Weingrow, M.D.; Decision and Order
Document Number: 2019-06834
Type: Notice
Date: 2019-04-08
Agency: Drug Enforcement Administration, Department of Justice